Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19–a randomised double-blinded placebo-controlled trial

Pradeesh Sivapalan, Charlotte Suppli Ulrik, Therese Sophie Lapperre, Rasmus Dahlin Bojesen, Josefin Eklöf, Andrea Browatzki, Jon Torgny Wilcke, Vibeke Gottlieb, Kjell Erik Julius Håkansson, Casper Tidemandsen, Oliver Tupper, Howraman Meteran, Christina Bergsøe, Eva Brøndum, Uffe Bodtger, Daniel Bech Rasmussen, Sidse Graff Jensen, Lars Pedersen, Alexander Jordan, Helene Priemé, Christian Søborg, Ida E. Steffensen, Dorthe Høgsberg, Tobias Wirenfeldt Klausen, Martin Steen Frydland, Peter Lange, Asger Sverrild, Muhzda Ghanizada, Filip Krag Knop, Tor Biering-Sørensen, Jens D. Lundgren, Jens-Ulrik Stæhr Jensen, ProPAC-COVID study group
European Respiratory Journal 2021; DOI: 10.1183/13993003.00752-2021

Article Information

DOI 
https://doi.org/10.1183/13993003.00752-2021
PubMed 
34083403
Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received March 15, 2021
  • Accepted May 22, 2021
  • Published online June 3, 2021.

Article Versions

Copyright & Usage 
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.

Author Information

  1. Pradeesh Sivapalan,
  2. Charlotte Suppli Ulrik,
  3. Therese Sophie Lapperre,
  4. Rasmus Dahlin Bojesen,
  5. Josefin Eklöf,
  6. Andrea Browatzki,
  7. Jon Torgny Wilcke,
  8. Vibeke Gottlieb,
  9. Kjell Erik Julius Håkansson,
  10. Casper Tidemandsen,
  11. Oliver Tupper,
  12. Howraman Meteran,
  13. Christina Bergsøe,
  14. Eva Brøndum,
  15. Uffe Bodtger,
  16. Daniel Bech Rasmussen,
  17. Sidse Graff Jensen,
  18. Lars Pedersen,
  19. Alexander Jordan,
  20. Helene Priemé,
  21. Christian Søborg,
  22. Ida E. Steffensen,
  23. Dorthe Høgsberg,
  24. Tobias Wirenfeldt Klausen,
  25. Martin Steen Frydland,
  26. Peter Lange,
  27. Asger Sverrild,
  28. Muhzda Ghanizada,
  29. Filip Krag Knop,
  30. Tor Biering-Sørensen,
  31. Jens D. Lundgren and
  32. Jens-Ulrik Stæhr Jensen,
  33. ProPAC-COVID study group*
  1. Corresponding author: Jens-Ulrik Jensen (jens.ulrik.jensen{at}regionh.dk)

  • ↵* A complete list of members in the Proactive Protection with Azithromycin and hydroxy-Chloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID) Study Group is provided in Supplementary Appendix 3. The ProPAC-COVID study is an initiative by the independent research network COP:TRIN (www.coptrin.dk).

View Full Text

Funding

  • Novo Nordisk Fonden

    NNF20SA0062834

Article usage

Article usage:

No statistics are available.

Altmetrics

Back to top
View this article with LENS
Email
Print
Citation Tools

Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19–a randomised double-blinded placebo-controlled trial
Pradeesh Sivapalan, Charlotte Suppli Ulrik, Therese Sophie Lapperre, Rasmus Dahlin Bojesen, Josefin Eklöf, Andrea Browatzki, Jon Torgny Wilcke, Vibeke Gottlieb, Kjell Erik Julius Håkansson, Casper Tidemandsen, Oliver Tupper, Howraman Meteran, Christina Bergsøe, Eva Brøndum, Uffe Bodtger, Daniel Bech Rasmussen, Sidse Graff Jensen, Lars Pedersen, Alexander Jordan, Helene Priemé, Christian Søborg, Ida E. Steffensen, Dorthe Høgsberg, Tobias Wirenfeldt Klausen, Martin Steen Frydland, Peter Lange, Asger Sverrild, Muhzda Ghanizada, Filip Krag Knop, Tor Biering-Sørensen, Jens D. Lundgren, Jens-Ulrik Stæhr Jensen,
European Respiratory Journal Jan 2021, 2100752; DOI: 10.1183/13993003.00752-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

Subjects